Table 5. Characteristics of individuals with HFpEF according to subphenotype category (N = 372).
| CHD (N = 84) | Metabolic Syndrome (N = 118) | Hypertension (N = 127) | Other (N = 43) | |
|---|---|---|---|---|
| Percentage of all HFpEF | 23% | 32% | 34% | 12% |
| Age at CHF, years | 81.1 (9.7) | 77.3 (10.7) | 85.4 (7.1) | 80.9 (11.8) |
| Age at Index Exam, years | 80.9 (7.5) | 76.2 (10.5) | 84.4 (6.6) | 79.9 (11.2) |
| Women, N (%) | 42 (50%) | 70 (59.3%) | 96 (75.6%) | 27 (62.8%) |
| BMI, kg/m2 | 27.9 (5.1) | 31.6 (6.3) | 25.7 (4.3) | 26.9 (3.6) |
| Systolic blood pressure, mm Hg | 142 (24) | 141 (26) | 142 (25) | 120 (12) |
| Diastolic blood pressure, mm Hg | 69 (13) | 69 (10) | 69 (10) | 67 (10) |
| Hypertension treatment, N (%) | 52 (80%) | 99 (85%) | 96 (76%) | 0 (0%) |
| Hypertension, N (%) | 60 (90%) | 109 (93%) | 127 (100%) | 0 (0%) |
| Diabetes, N (%) | 15 (33%) | 60 (53%) | 0 (0%) | 0 (0%) |
| Coronary heart disease, N (%) | 84 (100%) | 0 (0%) | 0 (0%) | 0 (0%) |
| Metabolic syndrome, N (%) | 27 (33%) | 118 (100%) | 0 (0%) | 0 (0%) |
| Estimated GFR (ml/min/1.73 m2) | 71 (29) | 64 (24) | 73 (22) | 92 (32) |
| Atrial fibrillation | 39 (46%) | 54 (46%) | 52 (41%) | 26 (60%) |
| COPD* | 6 (9%) | 19 (16%) | 28 (22%) | 8 (19%) |
* Percentages calculated based on the subsample with available data (excluding those with missing values).